Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls

Psychological Medicine
N DekkerL de Haan

Abstract

Cannabis use is common in patients with recent-onset schizophrenia and this is associated with poor disease outcome. More insight in the cognitive-motivational processes related to cannabis use in schizophrenia may inform treatment strategies. The present study is the first known to compare implicit and explicit cannabis associations in individuals with and without psychotic disorder. Participants consisted of 70 patients with recent-onset psychotic disorder and 61 healthy controls with various levels of cannabis use. Three Single-Category Implicit Association Tests (SC-IAT) were used to assess 'relaxed', 'active' and 'negative' implicit associations towards cannabis use. Explicit expectancies of cannabis use were assessed with a questionnaire using the same words as the SC-IAT. There were no differences in implicit associations between patients and controls; however, patients scored significantly higher on explicit negative affect expectancies than controls. Both groups demonstrated strong negative implicit associations towards cannabis use. Explicit relaxed expectancies were the strongest predictors of cannabis use and craving. There was a trend for implicit active associations to predict craving. The findings indicate that p...Continue Reading

References

Nov 18, 2015·Psychiatry Research·Emilie SchmitsEtienne Quertemont
Jan 13, 2015·Journal of Behavior Therapy and Experimental Psychiatry·Jianyong ChenMowei Shen
Mar 29, 2012·Psychological Medicine·N DekkerGROUP Investigators
Jan 1, 2017·Addiction Research & Theory·Alan K Davis

Citations

Dec 1, 1992·The Australian and New Zealand Journal of Psychiatry·D G ChaplowR R Kydd
Jan 1, 1995·Schizophrenia Bulletin·K T MueserM Molinaro
Dec 1, 1994·The Australian and New Zealand Journal of Psychiatry·M Dudley
Jan 1, 1995·Psychological Review·Anthony G Greenwald, Mahzarin R Banaji
Apr 1, 1994·Archives of General Psychiatry·Don H LinszenMarie E Lenior
Sep 1, 1993·Brain Research. Brain Research Reviews·T E Robinson, K C Berridge
Dec 1, 1996·Biological Psychiatry·M Hambrecht, H Häfner
Dec 12, 1997·Acta Psychiatrica Scandinavica·J Addington, V Duchak
Aug 27, 1998·Schizophrenia Bulletin·I L FowlerT J Lewin
Apr 22, 1999·The British Journal of Psychiatry : the Journal of Mental Science·R CantwellG Harrison
Feb 25, 2000·Psychological Review·T D WilsonT Y Schooler
Jun 6, 2000·Pharmacology, Biochemistry, and Behavior·F M LewekeH M Emrich
Nov 16, 2001·Journal of Personality and Social Psychology·Andrew Karpinski, J L Hilton
Nov 14, 2002·Journal of Abnormal Psychology·Reinout W WiersPeter J de Jong
Apr 16, 2003·Schizophrenia Bulletin·Catherine SpencerPatricia T Michie
Jun 6, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ingmar H A Franken
Aug 15, 2003·Journal of Personality and Social Psychology·Anthony G GreenwaldMahzarin R Banaji
Oct 31, 2003·The American Psychologist·Daniel Kahneman
Dec 9, 2003·Drug and Alcohol Review·Bob GreenRoss M C D Young
Mar 17, 2004·Social Psychiatry and Psychiatric Epidemiology·Sarah Van MastrigtD Addington
Mar 17, 2004·Psychological Assessment·Mark S Goldman, Jack Darkes
Mar 20, 2004·Personality & Social Psychology Bulletin·Thomas Holtgraves
Apr 10, 2004·Drug and Alcohol Dependence·Matt FieldBrendan P Bradley
May 20, 2004·Journal of Experimental Psychology. General·Klaus Rothermund, Dirk Wentura
Jun 3, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Deepak Cyril D'SouzaJohn Harrison Krystal
Nov 9, 2004·Journal of Behavior Therapy and Experimental Psychiatry·Jan De HouwerNatalie De Beul
Mar 15, 2005·Drug and Alcohol Review·Bob GreenRoss M C D Young
Mar 23, 2005·Biological Psychiatry·Deepak Cyril D'SouzaJohn Harrison Krystal
May 28, 2005·Addiction·Reinout W WiersFren T Y Smulders
Sep 7, 2005·Personality & Social Psychology Bulletin·Wilhelm HofmannManfred Schmitt
Dec 6, 2005·Addictive Behaviors·Katrijn Houben, Reinout W Wiers
Mar 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·Thomas R E BarnesEileen M Joyce
Apr 14, 2006·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·A W ZuardiF S Guimarães
Jun 8, 2006·The Australian and New Zealand Journal of Psychiatry·David SchofieldGail Brennan
Jul 13, 2006·Journal of Personality and Social Psychology·Andrew Karpinski, Ross B Steinman
Aug 18, 2006·Addictive Behaviors·Reinout W WiersJohnny de Kraker
Aug 29, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Cécile HenquetJim van Os
Sep 2, 2006·The British Journal of Psychiatry : the Journal of Mental Science·D WadeP D McGorry
Nov 23, 2006·Pharmacology, Biochemistry, and Behavior·Reinout W WiersAlan W Stacy
Dec 21, 2006·Experimental Psychology·Katrijn Houben, Reinout W Wiers
Mar 16, 2007·Acta Psychiatrica Scandinavica·J Addington, D Addington
May 2, 2007·Experimental and Clinical Psychopharmacology·Susan L AmesAlan W Stacy
May 23, 2007·Alcohol and Alcoholism : International Journal of the Medical Council on Alcoholism·Katrijn Houben, Reinout W Wiers

Related Concepts

Cannabinoids
Active brand of pseudoephedrine-triprolidine
Vigilance, Cortical
Visual Analog Pain Scale
Schizophrenia
Withdrawal Symptoms
Cannabis Dependence
Cannabis sativa plant
Mediator of activation protein
Mental Association

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.